News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Phase Genomics Wins $1.7M NIH Grant for Virus Discovery Platform Development
Seattle-based Phase Genomics has been awarded a $1.7 million grant from the National Institutes of Health. The funding will go toward creating a platform for
Screening to detect prior coronavirus infections launched by Adaptive Biotech, with Microsoft’s help
Adaptive Biotechnologies recently launched a new COVID-19 test that searches for T-cell responses against the virus, providing a more accurate way to detect prior infections.
Adaptive Biotechnologies eyes expansion to Europe
Adaptive Biotechnologies announced that it is expanding operations to Europe following a big 2020, in which the biotech company signed 35 new lab partnerships in
Veteran investor Dr Robert Glassman talks life sciences, immunotherapy and Umoja
“I don’t think I’ve ever been as honoured and excited to be part of somebody’s mission as I am with Umoja.” Veteran investor Dr. Robert
Novo Nordisk makes headway in bid to rule obesity market with stunning phase 3 semaglutide data
Life Science Washington member Novo Nordisk has taken one step forward in its ambition to move its Type 2 diabetes drug semaglutide into the obesity
Notch Therapeutics raises $85M for cancer treatments and plans to open Seattle location
Canada-based Notch Therapeutics announced its plans to open a Seattle research laboratory as part of its U.S. expansion, following a recent Series A funding round